Abiogen pharma spa Cingal Pre-filled Syringe 4Ml Abiogen

Reviews | Cingal Prefilled Syringe 4ml Abiogen - Cingal Medical Device is una A whitish, opaque, sterile, single-use suspension of a cross-linked hyaluronic acid (HA) gel with the addition of a corticosteroid (triamcinolone hexacetonide).| Presentation HA is an essential component of the extracellular matrix and is found in high concentrations in the synovial fluid of joints.| Hyaluronic acid is naturally biocompatible and its degradation process follows a normal physiological pathway.| HA is responsible for the viscoelastic properties of synovial fluid.| The synovial fluid of joints affected by osteoarthritis has una Lower concentration of HA and a reduced molecular weight of HA compared to healthy joints. Sodium hyaluronate supplements (viscosupplements) have been shown to be well tolerated in synovial joints affected by osteoarthritis and work to reduce pain and improve function through lubrication and mechanical support. The added corticosteroid triamcinolone hexacetonide has an anti-inflammatory action to provide short-term pain relief when used in an intra-articular injection of a joint affected by osteoarthritis. Sterility Sterile product (steam sterilization). Shelf life 36 months (from date of manufacture). Classification Class III Medical Device (Directive 93-42-EEC). Regulatory status CE Mark (Designated Body 0120). Indications Cingal is indicated as a viscoelastic supplement or as a substitute for synovial fluid in human joints. Cingal is suitable for the rapid and long-term relief of symptoms of joint diseases such as osteoarthritis. Cingal provides long-term relief of symptoms through lubrication and mechanical support, while also providing short-term pain relief thanks to triamcinolone hexacetonide. Contraindications Cingal consists of cross-linked hyaluronic acid, triamcinolone hexacetonide, and inactive ingredients. The following pre-existing conditions may result in relative or absolute contraindications to the use of Cingal: hypersensitivity to the active substance or to any of the excipients contained in Cingal; pre-existing infections in the skin area of the intended injection site; known infection in the target joint; known systemic coagulation disorders. The ancillary medicinal product triamcinolone hexacetonide is contraindicated in cases of: active tuberculosis; herpes simplex keratitis; acute psychosis; systemic mycoses and parasitic infections (strongyloides infections). | Instructions for use Cingal is injected directly into the chosen joint space using a sterile, disposable hypodermic needle of suitable thickness. | Healthcare personnel must insert the sterile needle into the Cingal syringe with una Aseptic technique approved by the health center. | The recommended needle size for knee injections is 18-21 gauge. | The final choice of needle for any procedure is the responsibility of the physician. | The physician must ensure that the needle has properly penetrated the synovial space of the joint before injecting Cingal. | Presentations Cingal is una sterile preparation supplied in una 4.0 ml disposable glass syringe. | Storage instructions Store at una temperature between 2 and 25°C. | Avoid freezing. | Before using Cingal, the refrigerated product must essere brought to room temperature (this process takes approximately 20 to 45 minutes). | Format: 4 ml pre-filled syringe.